Health Care & Life Sciences » Pharmaceuticals | Aarey Drugs & Pharmaceuticals Ltd.

Aarey Drugs & Pharmaceuticals Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
1,997
2,134
2,460
3,960
3,493
3,547
Cost of Goods Sold (COGS) incl. D&A
1,975
2,117
2,441
3,840
3,381
3,420
Gross Income
23
17
19
120
113
128
SG&A Expense
16
14
16
30
44
59
EBIT
7
3
4
90
69
69
Non Operating Income/Expense
2
2
2
4
32
43
Interest Expense
9
15
17
43
19
22
Pretax Income
13
14
18
80
82
90
Income Tax
3
3
5
21
20
24
Consolidated Net Income
11
11
13
59
62
65
Net Income
11
11
13
59
62
65
Net Income After Extraordinaries
11
11
13
59
62
65
Net Income Available to Common
11
11
13
59
62
65
EPS (Basic)
0.63
0.65
0.77
3.25
3.08
2.80
Basic Shares Outstanding
17
17
17
18
-
23
EPS (Diluted)
0.63
0.65
0.77
3.25
-
-
Diluted Shares Outstanding
17
17
17
18
-
23
EBITDA
14
14
10
97
76
79
Non-Operating Interest Income
14
24
29
29
-
-

About Aarey Drugs & Pharmaceuticals

View Profile
Address
1227, Hubtown Solaris
Mumbai Maharashtra 400009
India
Employees -
Website http://www.aareydrugs.com
Updated 07/08/2019
Aarey Drugs & Pharmaceuticals Ltd. engages in the trading of chemical products, solvent and drugs intermediates. The company also involves in the manufacture and supply of pharmaceutical raw materials and ingredients, and import and distribution of industrial chemicals. Its products include metronidazole and metronidazole benzoate.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.